United States · FDA National Drug Code directory
Giapreza
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68547-501_2c555078-770d-43d9-93e5-40e4cf5a4acf
- Product NDC
- 68547-501
- Form
- INJECTION
- Composition / generic term
- angiotensin II
- Labeler
- La Jolla Pharmaceutical Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180205
- Source listing expiry
- 20271231
Source-listed ingredients
- ANGIOTENSIN II — 2.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (68547-501-02) / 1 mL in 1 VIAL, SINGLE-DOSE · 68547-501-02
- 1 VIAL, SINGLE-DOSE in 1 CARTON (68547-501-07) / 1 mL in 1 VIAL, SINGLE-DOSE · 68547-501-07
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →